Charles R. Goulding and Andressa Bonafe examine how Johnson & Johnson’s spin-off of DePuy Synthes sets the stage for a more agile, 3D printing–driven orthopaedics powerhouse ready to redefine surgical innovation.
Charles R. Goulding and Andressa Bonafe examine how Johnson & Johnson’s spin-off of DePuy Synthes sets the stage for a more agile, 3D printing–driven orthopaedics powerhouse ready to redefine surgical innovation.